Anavex Life Sciences announced the appointment of Prof. Dr. Timo Grimmer, MD, to its Scientific Advisory Board. Prof. Dr. Grimmer served as National Coordinating Investigator for the ANAVEX2-73 Phase 2b/3 ANAVEX2-73-AD-004 study. Prof. Dr. Grimmer is a board-certified psychiatrist and psychotherapist and an Associate Professor working as a Specialist Registrar at the Department of Psychiatry and Psychotherapy, Technical University of Munich, School of Medicine, Munich, Germany.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on AVXL:
- Anavex Strengthens Scientific Advisory Board with Investigator from Phase 2b/3 Alzheimer’s Trial
- Anavex Life Sciences to Present at the 41st Annual J.P. Morgan Healthcare Conference
- Unusually active option classes on open December 6th
- Anavex downgraded to Neutral from Overweight at Cantor Fitzgerald
- Anavex Life Sciences to Announce Management Webcast and Conference Call on Monday December 5, 2022